These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 813933

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Persistence of rubella antibodies after vaccination: detection after experimental challenge.
    Banatvala JE, Best JM, O'Shea S, Dudgeon JA.
    Rev Infect Dis; 1985; 7 Suppl 1():S86-90. PubMed ID: 4001741
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.
    Ogra PL, Kerr-Grant D, Umana G, Dzierba J, Weintraub D.
    N Engl J Med; 1971 Dec 09; 285(24):1333-9. PubMed ID: 4107718
    [No Abstract] [Full Text] [Related]

  • 7. Rubella-specific serum and nasopharyngeal antibodies in volunteers with naturally acquired and vaccine-induced immunity after intranasal challenge.
    Harcourt GC, Best JM, Banatvala JE.
    J Infect Dis; 1980 Aug 09; 142(2):145-55. PubMed ID: 7410897
    [Abstract] [Full Text] [Related]

  • 8. [Diagnosis of rubella by demonstrating rubella-specific 19 S and 7 S antibodies (author's transl)].
    Dibbert HJ.
    Zentralbl Bakteriol Orig A; 1976 Mar 09; 234(2):145-58. PubMed ID: 1274496
    [Abstract] [Full Text] [Related]

  • 9. Rubella serology by solid-phase radioimmunoassay: its potential for screening programmes.
    Sugishita C, O'Shea S, Best JM, Banatvala JE.
    Clin Exp Immunol; 1978 Jan 09; 31(1):50-4. PubMed ID: 639348
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Development of immunoglobulin M-antibodies after rubella immunization with RA27/3 attenuated live vaccine in teen-agers: remaining problems.
    Braito A, Fanti O, Rossolini GM, Cellesi C.
    Boll Ist Sieroter Milan; 1978 Jan 09; 70(1-2):443-8. PubMed ID: 1670047
    [Abstract] [Full Text] [Related]

  • 12. Rubella in Orkney: seroepidemiology and vaccination.
    Moffat MA, Heywood SN, Laughton E, Gould JJ, Freestone DS.
    J Hyg (Lond); 1977 Jun 09; 78(3):419-27. PubMed ID: 266542
    [Abstract] [Full Text] [Related]

  • 13. [Rubella vaccination with "Cendehill" and "RA 27/3". Reinfection of vaccinated and naturally immune persons compared with the infection rate of susceptible persons within a 3-resp. 5-year observation period (author's transl)].
    Thomssen R.
    Zentralbl Bakteriol Orig A; 1976 Nov 09; 236(2-3):163-84. PubMed ID: 1015009
    [Abstract] [Full Text] [Related]

  • 14. Vaccination of seronegative high-risk populations with attenuated rubella vaccine.
    Lehtinen MO, Hakkarainen K, Leinikki PO, Lehtinen TK, Mattila LM, Helle EP.
    Ann Clin Res; 1982 Dec 09; 14(5-6):213-9. PubMed ID: 7171230
    [Abstract] [Full Text] [Related]

  • 15. Screening for rubella antibodies by a single radial haemolysis test.
    Degré M, Rollag H.
    NIPH Ann; 1979 Dec 09; 2(2):25-30. PubMed ID: 398458
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Study of young women vaccinated against rubella virus for 10 years in Taiwan.
    Lin DB, Kao CL, Lee CY.
    Southeast Asian J Trop Med Public Health; 1996 Dec 09; 27(4):707-14. PubMed ID: 9253871
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.